{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:59:18Z","timestamp":1790027958186,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. Multiparametric MRI-based radiomics shows promise for prognosis, yet most studies fuse all sequences without quantifying their individual contributions. We systematically compared the prognostic value of features from single sequences and comprehensive fusions for survival classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included glioblastoma patients from TCIA. Quantitative features were extracted from T1, T1-GD, T2, and T2-FLAIR images. Univariate ROC analyses with Benjamini-Hochberg false discovery rate correction assessed each feature\u2019s prognostic value. For multivariate modeling, combining univariate analysis with the maximum relevance minimum redundancy algorithm, was used to select the top predictors for each model. Logistic regression models were then built using features from single sequences, dual-sequence fusions, and a comprehensive four-sequence fusion. Performance was compared using repeated random subsampling validation with AUC as the metric.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Univariate analysis identified 249 features with significant prognostic power (T1-GD: 79; T2: 58; T2-FLAIR: 57; T1: 55). In the multivariate analysis, the four-sequence fusion model achieved the highest performance on the training cohort (AUC: 0.8467), but this advantage did not generalize to the validation cohorts. On the validation set, single-sequence models achieved AUCs ranging from 0.6599 to 0.7010, with the T2 model performing best. The dual-sequence model combining features from T1-GD and T2 sequences yielded the highest overall performance, achieving a mean validation AUC of 0.7066. Notably, this targeted two-sequence model outperformed the more complex four-sequence model (AUC: 0.7030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For glioblastoma survival prediction, a strategic selection of complementary imaging sequences might be more effective than an indiscriminate aggregation of all available structural MRI data. However, this finding is currently specific to this particular dataset and clinical task. Future research using large-scale data with multiple tumor types and clinical objectives is necessary to explore the broader generalizability of these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1743451","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:39:37Z","timestamp":1768196377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating sequence contributions to MRI radiomics for glioblastoma survival: single vs fusion models"],"prefix":"10.3389","volume":"15","author":[{"given":"Ruirui","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-oncology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro-oncology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov095","article-title":"Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials","volume":"17","author":"Ellingson","year":"2015","journal-title":"Neuro-oncology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-811161-1.00007-4","article-title":"Brain metastases: neuroimaging","volume":"149","author":"Pope","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12880-024-01434-x","article-title":"Histopathological correlations of CT-based radiomics imaging biomarkers in native kidney biopsy","volume":"24","author":"Choi","year":"2024","journal-title":"BMC Med Imaging"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.7150\/thno.34149","article-title":"A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016160845","article-title":"Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models","volume":"280","author":"Kickingereder","year":"2016","journal-title":"Radiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12880-025-01788-w","article-title":"Exploring the associations between features from multi-parametric MR images in Glioblastoma using radiomics","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Med Imaging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12880-025-01823-w","article-title":"Non-invasive liver fibrosis screening on CT images using radiomics","volume":"25","author":"Yoo","year":"2025","journal-title":"BMC Med Imaging"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","journal-title":"Neuro-oncology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26010","article-title":"Radiomics strategy for glioma grading using texture features from multiparametric MRI","volume":"48","author":"Tian","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06069-z","article-title":"A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival","volume":"29","author":"Zhang","year":"2019","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41597-022-01560-7","article-title":"The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics","volume":"9","author":"Bakas","year":"2022","journal-title":"Sci Data"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-013-9622-7","article-title":"The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository","volume":"26","author":"Clark","year":"2013","journal-title":"J Digital Imaging"},{"key":"B20","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Internal Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Society: Ser B (Methodol)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.21037\/qims-20-681","article-title":"Prediction of neoadjuvant chemotherapy response in high-grade osteosarcoma: added value of non-tumorous bone radiomics using CT images","volume":"11","author":"Xu","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"215005","DOI":"10.1088\/1361-6560\/ac2ea5","article-title":"Generalized methodology for radiomic feature selection and modeling in predicting clinical outcomes","volume":"66","author":"Yang","year":"2021","journal-title":"Phys Med Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1109\/TPAMI.2005.159","article-title":"Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy","volume":"27","author":"Peng","year":"2005","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt383","article-title":"mRMRe: an R package for parallelized mRMR ensemble feature selection","volume":"29","author":"De Jay","year":"2013","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07845-6","article-title":"Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques","volume":"31","author":"Bathla","year":"2021","journal-title":"Eur Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.23421","article-title":"Defining the biological basis of radiomic phenotypes in lung cancer","volume":"6","author":"Grossmann","year":"2017","journal-title":"elife"},{"key":"B29","doi-asserted-by":"publisher","first-page":"125013","DOI":"10.1088\/1361-6560\/ad51c7","article-title":"Exploring the biological basis of CT imaging features in pancreatic neuroendocrine tumors: a two-center study","volume":"69","author":"Xu","year":"2024","journal-title":"Phys Med Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1743451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:39:39Z","timestamp":1768196379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1743451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":29,"alternative-id":["10.3389\/fonc.2025.1743451"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1743451","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1743451"}}